N. Shirai

Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma.

T. Katabami, H. Kato, N. Shirai, 2005, Endocrine journal.

Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.

D. Jerina, A. Conney, W. Levin, 1986, Cancer research.

Tumorigenicity of four optically active bay-region 3,4-diol 1, 2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine on mouse skin and in newborn mice.

D. Jerina, A. Conney, R. Chang, 2000, Carcinogenesis.

High tumorigenicity of the 3,4-dihydrodiol of 7-methylbenz[c]acridine on mouse skin and in newborn mice.

D. Jerina, A. Conney, G. Holder, 1986, Cancer research.

Discrepancies in results of low-and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome.

T. Katabami, N. Shirai, Satoru Naito, 2005, Endocrine journal.

The proximate carcinogen trans-3,4-dihydroxy-3,4-dihydro-dibenz[c,h]acridine is oxidized stereoselectively and regioselectively by cytochrome 1A1, epoxide hydrolase and hepatic microsomes from 3-methylcholanthrene-treated rats.

D. Jerina, A. Chadha, J. Adams, 1999, Chemico-biological interactions.

Functional properties of synthetic N-acyl-L-homoserine lactone analogs of quorum-sensing gram-negative bacteria on the growth of human oral squamous carcinoma cells

Kenji Takahashi, I. Kashiwakura, H. Suga, 2012, Investigational New Drugs.